Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Muscular Dystrophy

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Using CRISPR to Treat Muscular Dystrophy

CRISPR

Using CRISPR to Treat Muscular Dystrophy

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M08-19-NI-021Aug 15, 2019

AbCellera Biologics Inc.

Duchenne Muscular Dystrophy

Fight Against Duchenne Muscular Dystrophy Gets Major Funding Boost

AbCellera Biologics Inc.

PR-M09-18-NI-063Sep 21, 2018